MASTALONE INTRAMAMMARY SUSPENSION FOR LACTATING COWS

Land: Australia

Språk: engelsk

Kilde: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Kjøp det nå

Informasjon til brukeren (PIL)

19-06-2017

Preparatomtale (SPC)

19-06-2017

Aktiv ingrediens:

NEOMYCIN AS THE SULFATE; OLEANDOMYCIN AS THE PHOSPHATE; OXYTETRACYCLINE AS OXYTETRACYCLINE HYDROCHLORIDE

Tilgjengelig fra:

ZOETIS AUSTRALIA PTY LTD

INN (International Name):

oxytetracycline as HCl(18.5mg/mL)+oleandmycin as PO4(10mg/mL) + others

Legemiddelform:

MISC. INTRA MAMMARY

Sammensetning:

NEOMYCIN AS THE SULFATE ANTIBIOTIC Active 100.0 mg/10ml; OLEANDOMYCIN AS THE PHOSPHATE ANTIBIOTIC Active 100.0 mg/10ml; OXYTETRACYCLINE AS OXYTETRACYCLINE HYDROCHLORIDE ANTIBIOTIC Active 185.0 mg/10ml

Enheter i pakken:

20 x 10mL

Klasse:

VM - Veterinary Medicine

Produsert av:

ZOETIS AUSTRALIA

Terapeutisk gruppe:

CATTLE LACTATING | BOVINE

Terapeutisk område:

ANTIBIOTIC & RELATED

Indikasjoner:

Produkt oppsummering:

Poison schedule: 4; Withholding period: WHP: MEAT - DO NOT USE LESS THAN 30 DAY S BEFORE SLAUGHTER FOR HUMAN CONSUMPTIO N. MILK - MILK TAKEN FROM ANIMALS WITHI N 7 DAYS FOLLOWING TREATMENT MUST NOT B E USED FOR HUMAN CONSUMPTION OR SUPPLIE D FOR PROCESSING. ESI:This product doe s not have an ESI established.; Host/pest details: CATTLE LACTATING: [ANTIBIOTIC - ANTI-INFECTIVE]; A broad spectrum antibiotic combination for the treatment of mastitis in lactating cattle.

Autorisasjon status:

Registered

Autorisasjon dato:

2023-07-01

Informasjon til brukeren

MASTALONE INTRAMAMMARY SUSPENSION FOR LACTATING COWS
49851/106743
Product Name:
APVMA Approval No:
Label Name:
MASTALONE INTRAMAMMARY SUSPENSION FOR LACTATING COWS
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
185 mg/10ml OXYTETRACYCLINE AS OXYTETRACYCLINE HYDROCHLORIDE
100 mg/10ml OLEANDOMYCIN AS PHOSPHATE
100 mg/10ml NEOMYCIN AS SULFATE
Claims:
A broad spectrum antibiotic combination for the treatment of mastitis
in lactating cattle
Net Contents:
20 x 10mL
Directions for Use:
Dosage and
Administration:
Infuse 1 syringe every 24 hours for 3 treatments per infected quarter.
In cold weather warm
syringe to body temperature.
The entire contents (10 mL) of one syringe should be infused into the
affected quarter
immediately after milking. Ensure that the affected quarters are
thoroughly stripped out
before treatment. Treatment should be repeated at 24 hour intervals
for three days. Care
should be taken to properly clean and disinfect the tip of the teat to
prevent introduction of
contaminants. Care should also be taken to avoid contamination of the
tip of the syringe
after removal of the cap and after prior to insertion into the teat
canal. After contents are
infused, gently massage the preparation upwards, working the syringe
contents into the
mammary gland.
In addition to therapeutic treatment, cleanliness of dairy, milking
equipment, thoroughness
of milking techniques, operator care and correctly adjusted milking
machines are of
paramount importance.
The routine use of suitable commercial teat dips for all lactating
cows is highly
recommended.
General Directions:
The combination of three antibiotics in MASTALONE is designed to
provide maximum
coverage against most of the known causative organisms associated with
bacterial mastitis. RLP APPROVED
Terramycin* (oxytetracycline hydrochloride) is actice against wide
range of Gram positive
and Gram negative organisms.
Oleandomycin provides specific reinforcement against Gram positive
organisms

read_full_document

Preparatomtale

PRODUCT NAME: MASTALONE
PAGE: 1 OF 5
This revision issued: August, 2012
MATERIAL SAFETY DATA SHEET
Issued by: Pfizer Australia Pty Ltd
Phone: 1800 814 883
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
Pfizer Australia Pty Ltd
38-42 Wharf Road
West Ryde NSW 2114
Tel: 1800 884 883
Fax: (02) 9850 3399
____________________________________
PFIZER AUSTRALIA PTY LTD
A.B.N. 50 008 422 348
SUBSTANCE:
Blend of ingredients. Active ingredients are antibiotics.
TRADE NAME:
MASTALONE
PRODUCT USE:
Broad spectrum antibiotic for the treatment of mastitis in lactating
cattle.
CREATION DATE:
SEPTEMBER, 2006
THIS VERSION ISSUED:
AUGUST, 2012
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of ASCC.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S45. In case of accident or if you feel unwell, contact a doctor or
Poisons Information Centre
immediately (show the label where possible).
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
E
E
E
M
M
M
E
E
E
R
R
R
G
G
G
E
E
E
N
N
N
C
C
C
Y
Y
Y
O
O
O
V
V
V
E
E
E
R
R
R
V
V
V
I
I
I
E
E
E
W
W
W
PHYSICAL DESCRIPTION & COLOUR
: Yellow viscous liquid.
ODOUR:
Mild odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product. A
significant ingredient is an
antibiotic. Any person with a history of allergies to this class of
substances should avoid all contact with this product
as it may cause sensitisation.
P
P
P
O
O
O
T
T
T
E
E
E
N
N
N
T
T
T
I
I
I
A
A
A
L
L
L
H
H
H
E
E
E
A
A
A
L
L
L
T
T
T
H
H
H
E
E
E
F
F
F
F
F
F
E
E
E
C
C
C
T
T
T
S
S
S
This is an antibiotic preparation, and has mild acute effects.
However, if taken in large quantities, or under non
medical su

read_full_document